This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Welcome to BPI Europe 2024!
9-12 April 2024Messe Wien Congress Centre, Vienna

Robyn Emmins
Scientific Director, Cell Line Development at GSK


Robyn Emmins, PhD (Molecular Microbiology, University of Edinburgh 2006) joined GSK in 2009 following Post-Graduate and Post-Doctoral research (University of Newcastle, 2009) exploring the genetic regulation of cell division pathways in microbial systems. Upon joining GSK, she led the platform development for microbial biopharmaceutical CLD before diversifying into platform enabling research to evolve GSK’s CHO expression systems. Robyn has led the Biopharmaceutical Cell Line Development team since 2020 and has enjoyed deploying automation (both physical and digital) and advanced genetic tools to augment the speed, reliability, and quality of cell lines to support GSK’s biologics portfolio.

Agenda Sessions

  • KEYNOTE: Look before you leap: Use of digital tools for clone selection and optimisation of novel quality assessments to enable efficiencies in Cell Line Development